| Ytd | -98.62% | |
| 1y | -99.55% |
| Open | 1.06 | Prev Close | 1.13 | Low | 1.00 | High | 1.18 | Mkt Cap | 3.99M |
| Vol | 409.78K | Avg Vol | 1.31M | EPS | 1377.40 | P/E | 0.00 | Forward P/E | -0.41 |
| Beta | 3.73 | Short Ratio | 0.45 | Inst. Own | 7.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-31 | 50-d Avg | 2.83 | 200-d Avg | 70.75 | 1yr Est | 9.00 |
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m
STOCKHOLM — June 17, 2026 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company speci